The cardiovascular pharmacology of bunolol, a new beta adrenergic blocking agent.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D003331:Coronary Vessels / Q000187:drug effects; D005260:Female; D005263:Femoral Artery; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009281:Naphthalenes / Q000008:administration & dosage / Q000494:pharmacology*; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D011984:Sensory Receptor Cells / Q000187:drug effects; D013565:Sympatholytics / Q000494:pharmacology*; D014628:Vagotomy; D014630:Vagus Nerve / Q000502:physiology
D000319:Adrenergic beta-Antagonists; D009281:Naphthalenes; D013565:Sympatholytics; D012110:Reserpine; D011433:Propranolol; D007545:Isoproterenol